Clinical trials
Terminated Neuralgia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
83 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 9 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 10 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 83 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Grünenthal GmbH | 4 |
| Centre Hospitalier Universitaire de Saint Etienne | 3 |
| Guy's and St Thomas' NHS Foundation Trust | 3 |
| National Institute of Nursing Research (NINR) | 3 |
| AstraZeneca | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| Novartis Pharmaceuticals | 2 |
| UMC Utrecht | 2 |
| University Hospital, Clermont-Ferrand | 2 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuralgia | 83 |
| Pain | 19 |
| Chronic Pain | 10 |
| Diabetic Neuropathies | 10 |
| Agnosia | 6 |
| Peripheral Nervous System Diseases | 5 |
| Facial Pain | 4 |
| Neuralgia, Postherpetic | 4 |
| Postoperative Pain | 4 |
| Spinal Cord Injuries | 4 |
Trials
Showing 76 to 83 of 83. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.